Patent ID: 11919900
Assignee: KING FAISAL UNIVERSITY
Field: Organic fine chemistry (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 7:
8. A method of treating tuberculosis selected from the group consisting of multi drug resistant (MDR) strains of Mycobacterium tuberculosis, extensively drug resistant (XDR) strains of Mycobacterium tuberculosis, H37Rv strains of Mycobacterium tuberculosis, and a combination thereof in a patient, comprising administering to a patient in need thereof a therapeutically effective amount of a compound having the formula I:, or a pharmaceutically acceptable salt, ester, stereoisomer, or solvate thereof, wherein:
R1 is selected from the group consisting of hydrogen, chlorine, bromine, fluorine, cyano, nitro, and methoxy;
R2 is —COOCH3 or —COOC2H5; and
R3 is hydrogen or —COOCH3.